CARMELA: assessment of cardiovascular risk in seven Latin American cities.
暂无分享,去创建一个
Alejandro Macchia | Jorge Escobedo | Fabio Pellegrini | P. Touboul | C. Boissonnet | H. Schargrodsky | F. Pellegrini | J. Escobedo | Pierre-Jean Touboul | Carlos Pablo Boissonnet | Honorio Silva | Herman Schargrodsky | Elinor Wilson | A. Macchia | B. Champagne | E. Wilson | Rafael Hernández-Hernández | Beatriz Marcet Champagne | Raúl Vinueza | Luis Carlos Silva Ayçaguer | L. C. Silva Ayçaguer | R. Hernández-Hernández | H. Silva | R. Vinueza
[1] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[2] G. E. Who,et al. Preventing chronic diseases: a vital investment , 2005 .
[3] P. Ordunez,et al. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? , 2001, Revista panamericana de salud publica = Pan American journal of public health.
[4] J. Mackay. 10th World Conference on Tobacco or Health. , 1997, Tobacco control.
[5] N. Unwin,et al. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .
[6] S. Yusuf,et al. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.
[7] K. Reynolds,et al. Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.
[8] E. Vicaut,et al. Design, Baseline Characteristics and Carotid Intima-Media Thickness Reproducibility in the PARC Study , 2005, Cerebrovascular Diseases.
[9] T. Macdonald. Preventing Chronic Diseases: A Vital Investment , 2006 .
[10] Other. Human Development Report 2005: International cooperation at a crossroads: aid, trade and security in an unequal world , 2005 .
[11] Rachel Leach,et al. Rethinking the “Diseases of Affluence” Paradigm: Global Patterns of Nutritional Risks in Relation to Economic Development , 2005, PLoS medicine.
[12] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[13] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[14] Tom Fahey,et al. Predictive accuracy of the Framingham coronary risk score in British men:prospective cohort study , 2003, BMJ : British Medical Journal.
[15] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[16] E. Vicaut,et al. Mannheim Intima-Media Thickness Consensus , 2004, Cerebrovascular Diseases.
[17] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[18] J. Shaw,et al. Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[19] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[20] D. Burkitt. Chapter 9 – Diseases of Affluence , 1980 .
[21] S. Yusuf,et al. Emerging epidemic of cardiovascular disease in developing countries. , 1999, Circulation.
[22] E. Ford. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. , 2005, Diabetes care.
[23] G. Mensah,et al. Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia Among US Adults: Findings From the National Health and Nutrition Examination Survey, 1999 to 2000 , 2003, Circulation.
[24] Alan D. Lopez,et al. A descriptive model of the cigarette epidemic in developed countries , 1994 .
[25] Salim Yusuf,et al. Risk Factors for Acute Myocardial Infarction in Latin America: The INTERHEART Latin American Study , 2007, Circulation.
[26] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[27] G. Guindon,et al. Tobacco control country profiles , 2003 .
[28] W. Castelli,et al. Epidemiology of coronary heart disease: the Framingham study. , 1984, The American journal of medicine.
[29] P. Raskin,et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.
[30] Michiel L Bots,et al. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies , 2006, Current medical research and opinion.
[31] A. Omran. The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.
[32] Ihab Hajjar,et al. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. , 2003, JAMA.
[33] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[34] G. Colditz,et al. The disease burden associated with overweight and obesity. , 1999, JAMA.